News
DHR
221.09
+2.43%
5.25
Stanley Black & Decker Inc. Stock Climbs 3.9%, Outperforms Peers
Dow Jones · 11h ago
Danaher Schedules Third Quarter 2026 Earnings Conference Call
PR Newswire · 12h ago
XLV, PFE, BMY, DHR: Large Outflows Detected at ETF
NASDAQ · 17h ago
CMS announces new preliminary Medicare payment rates for lab services
TipRanks · 1d ago
Corning Inc. Stock Climbs 5.9%, Outperforms Peers
Dow Jones · 1d ago
White House moves to take control of N.I.H. grants, NY Times reports
TipRanks · 1d ago
Goldman Sachs Sticks to Their Buy Rating for Danaher (DHR)
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Argenx Se (ARGX) and Boston Scientific (BSX)
TipRanks · 1d ago
Weekly Report: what happened at DHR last week (0914-0918)?
Weekly Report · 1d ago
Did Reduced Growth Outlook Just Shift Danaher Stock Investment Narrative?
Simply Wall St · 2d ago
Jefferies Sticks to Their Buy Rating for Danaher (DHR)
TipRanks · 4d ago
2 Unpopular Stocks That Should Get More Attention and 1 We Question
Barchart · 5d ago
Danaher (DHR) Lands Key Spot In Global Single Use Bioreactors Forecast
Simply Wall St · 5d ago
Revvity Inc. Stock Climbs 4.0%, Outperforms Peers
Dow Jones · 6d ago
Danaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi
TipRanks · 6d ago
Revvity Inc. Stock Climbs 9.1%, Outperforms Peers
Dow Jones · 09/15 20:33
Danaher Announces Quarterly Dividend
PR Newswire · 09/15 20:15
Press Release: Danaher Announces Quarterly Dividend
Dow Jones · 09/15 20:15
ELV or DHR: Which Is the Better Value Stock Right Now?
NASDAQ · 09/15 15:40
Corning Inc. Stock Falls 13.7%, Underperforms Peers
Dow Jones · 09/14 20:34
More
Webull provides a variety of real-time DHR stock news. You can receive the latest news about Danaher Corporation through multiple platforms. This information may help you make smarter investment decisions.
About DHR
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services. The Company also provides pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings.